EUDA Health Holdings Limited Form 6-K Summary
Business context and reporting period
EUDA Health Holdings Limited, a foreign private issuer, filed this Form 6-K for August 2023. The filing, dated August 14, 2023, reports a Nasdaq listing-compliance matter rather than periodic operating or financial results.
Key financial and operating metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial-performance metrics.
Material changes versus the prior comparable period
No comparative financial information or prior-period operating changes are disclosed.
Guidance, outlook, risks, contingencies, and unusual items
- On August 10, 2023, Nasdaq notified the Company that it was not in compliance with the $1.00 minimum bid-price requirement under Nasdaq Listing Rule 5550(a)(2).
- The deficiency was based on the Company’s closing bid price being below $1.00 for 30 consecutive business days through August 9, 2023.
- The notice did not immediately delist the Company’s securities.
- The Company received an initial 180-calendar-day period to regain compliance. Compliance can generally be restored if the bid price closes at or above $1.00 for at least 10 consecutive business days during that period.
- If eligible, the Company may receive an additional 180-calendar-day compliance period, subject to meeting applicable continued-listing requirements and notifying Nasdaq of its intent to cure the deficiency, potentially through a reverse stock split.
- If compliance is not restored, Nasdaq may issue a delisting determination. The Company would have the right to appeal such a determination to a Hearings Panel.
- Management stated that it intends to monitor the closing bid price and is considering options to regain compliance.
- The Company stated that receipt of the notice does not affect its business, operations, or SEC reporting requirements.
Important facts for investors to verify
- The exact expiration date of the initial 180-day compliance period and whether an additional period was granted.
- Whether the Company restored compliance with the $1.00 minimum bid-price requirement.
- Whether the Company pursued or completed a reverse stock split or another remedial action.
- Any subsequent Nasdaq delisting notice, appeal, or change in trading status.
- The Company’s financial condition and liquidity, which are not provided in this filing.